\

 

 

Home About Us Contact Us

 

Table of Content - Volume 10 Issue 2 - May 2018


 

A comparative study of efficacy of single dose of intravenous ferric carboxymaltose over oral iron therapy in severe iron deficiency Anemia

 

Makarand Balwant Mane1*, Priyanka Makarand Mane2,Akshay Shirshat3,Tejas Uttamrao Bhosale4

 

1Associate Professor, 3,4Senior Resident, Department of Medicine} {2Assistant Professor, Department of Microbiology} Krishna Hospital, P B Road, Malkapur Karad, Satara, Malkapur, INDIA.

Email: makarand.mane@gmail.com

 

REFERENCES

  1. S. Killip, J. M. Bennett, and M. D. Chambers, “Iron deficiency anemia,” American Family Physician, vol. 75, no. 5, pp. 671– 678, 2007
  2. J. Umbreit, “Iron deficiency: a concise review,” American Journal of Hematology, vol. 78, no. 3, pp. 225–231, 2005.
  3.  Ministry of Health and Family Welfare, Government of India. Guidelines for control of Iron deficiency anaemia. New Delhi: Ministry of Health and Family Welfare, Government of India; 2013. Available at: http://www.unicef.org/india/10._National_Iron_Plus_Initiative_Guidelines_for_Control_of_IDA.pdf. Accessed 18 January 2018.
  4. Killip, S., Bennett, J. and Chambers, M. (2007) Iron deficiency anemia. Am Fam Physician 75: 671–678.
  5. Salve MP, Inamdar SA, Bhaumik DK, Patil AR. Single dose intravenous carboxymaltose versus oral iron therapy in the treatment of anaemia in postpartum patients in a rural area. Journal of Evidence Based Medicine and Healthcare. 2017 Jan 1;4(14):842-7.
  6. Naqash A, Ara R, Bader GN. Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials. BMC women's health. 2018 Dec;18(1):6.